切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2023, Vol. 09 ›› Issue (02) : 137 -142. doi: 10.3877/cma.j.issn.2095-9605.2023.02.011

综述

减重代谢外科在心血管疾病防治中的临床意义与前景
闫海, 邵怡凯, 姚琪远()   
  1. 200040 上海,复旦大学附属华山医院普外科
  • 收稿日期:2023-02-23 出版日期:2023-05-30
  • 通信作者: 姚琪远

Clinical significance and prospect of bariatric metabolic surgery in the prevention and treatment of cardiovascular diseases

Hai Yan, Yikai Shao, Qiyuan Yao()   

  1. Department of General Surgery, Huashan Hospital of Fudan University, Shanghai 200040, China
  • Received:2023-02-23 Published:2023-05-30
  • Corresponding author: Qiyuan Yao
引用本文:

闫海, 邵怡凯, 姚琪远. 减重代谢外科在心血管疾病防治中的临床意义与前景[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 137-142.

Hai Yan, Yikai Shao, Qiyuan Yao. Clinical significance and prospect of bariatric metabolic surgery in the prevention and treatment of cardiovascular diseases[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(02): 137-142.

减重手术作为长期有效治疗肥胖症和2型糖尿病(T2DM)的方法之一,已经取得了内外科共同的认可。随着减重代谢外科的快速发展、临床医生的学术研究和20多年的经验沉积,诸多研究发现减重手术可以通过改善肥胖相关心血管危险因素预防并治疗肥胖最主要的远期合并症——心血管疾病。因此,减重手术有望成为未来治疗肥胖症患者心血管代谢性疾病的新型治疗手段之一。本综述旨在探讨外科减重对心血管疾病防治中的临床意义与前景。

Bariatric surgery, as one of the long-term and effective treatments for obesity and type 2 diabetes mellitus (T2DM), has gained common recognition in the Department of Medicine and Surgery. With the rapid development of bariatric metabolic surgery, the academic research of clinicians, and the accumulation of more than 20 years of experience, many studies have found that bariatric surgery can prevent and treat cardiovascular disease, the most major long-term complication of obesity, by improving obesity-related cardiovascular risk factors. Therefore, bariatric surgery is expected to be one of the new therapeutic methods for cardiovascular metabolic diseases in obese patients in the future. This review aims to explore the clinical significance and prospect of bariatric metabolic surgery in the prevention and treatment of cardiovascular diseases.

图1 减重手术与心血管疾病注:图源自Bariatric surgery and cardiovascular disease:a systematic review and meta-analysis
[1]
Aminian A, Zajichek A, Arterburn DE, et al. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity [J]. Jama, 2019, 322(13): 1271-1282.
[2]
Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial [J]. Lancet, 2021, 397(10271): 293-304.
[3]
Aminian A, Al-Kurd A, Wilson R, et al. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis [J]. Jama, 2021, 326(20): 2031-2042.
[4]
Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(3): 160-169.
[5]
Schiavon CA, Bhatt DL, Ikeoka D, et al. Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension : A Randomized Clinical Trial [J]. Ann Intern Med, 2020, 173(9): 685-693.
[6]
Arterburn DE, Telem DA, Kushner RF, et al. Benefits and Risks of Bariatric Surgery in Adults: A Review [J]. Jama, 2020, 324(9): 879-887.
[7]
Mentias A, Aminian A, Youssef D, et al. Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population [J]. J Am Coll Cardiol, 2022, 79(15): 1429-1437.
[8]
Afshin A, Forouzanfar MH, Reitsma MB, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years [J]. N Engl J Med, 2017, 377(1): 13-27.
[9]
Kannel WB, D'Agostino RB, Cobb J L. Effect of weight on cardiovascular disease [J]. Am J Clin Nutr, 1996, 63(3 Suppl): 419s-422s.
[10]
Doumouras AG, Wong JA, Paterson JM, et al. Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:: A Population-Based Retrospective Cohort Study [J]. Circulation, 2021, 143(15): 1468-1480.
[11]
Ricci C, Gaeta M, Rausa E, et al. Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up [J]. Obes Surg, 2015, 25(3): 397-405.
[12]
Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012 [J]. JAMA Surg, 2014, 149(3): 275-287.
[13]
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications [J]. Jama, 2014, 311(22): 2297-2304.
[14]
Lee GK, Cha YM. Cardiovascular benefits of bariatric surgery [J]. Trends Cardiovasc Med, 2016, 26(3): 280-289.
[15]
Shen SC, Wang W, Tam KW, et al. Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy [J]. Obes Surg, 2019, 29(1): 221-229.
[16]
Billeter AT, Scheurlen KM, Probst P, et al. Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus [J]. Br J Surg, 2018, 105(3): 168-181.
[17]
Sheng B, Truong K, Spitler H, et al. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis [J]. Obes Surg, 2017, 27(10): 2724-2732.
[18]
Fisher DP, Johnson E, Haneuse S, et al. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity [J]. Jama, 2018, 320(15): 1570-1582.
[19]
Courcoulas AP, King WC, Belle SH, et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study [J]. JAMA Surg, 2018, 153(5): 427-434.
[20]
Wang FG, Yu ZP, Yan WM, et al. Comparison of safety and effectiveness between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy: A meta-analysis and systematic review [J]. Medicine (Baltimore), 2017, 96(50): e8924.
[21]
Puzziferri N, Roshek TB, 3rd, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review [J]. Jama, 2014, 312(9): 934-942.
[22]
Hallersund P, Sjöström L, Olbers T, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study [J]. PLoS One, 2012, 7(11): e49696.
[23]
Pareek M, Bhatt DL, Schiavon CA, et al. Metabolic Surgery for Hypertension in Patients With Obesity [J]. Circ Res, 2019, 124(7): 1009-1024.
[24]
Buchwald H, Varco RL, Boen JR, et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias [J]. Arch Intern Med, 1998, 158(11): 1253-1261.
[25]
Jamialahmadi T, Reiner Ž, Alidadi M, et al. The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis [J]. Oxid Med Cell Longev, 2021, 2021: 4136071.
[26]
Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery [J]. Obes Res, 2002, 10(9): 903-910.
[27]
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery [J]. N Engl J Med, 2004, 351(26): 2683-2693.
[28]
Chiappetta S, Jamadar P, Stier C, et al. The role of C-reactive protein after surgery for obesity and metabolic disorders [J]. Surg Obes Relat Dis, 2020, 16(1): 99-108.
[29]
Askarpour M, Khani D, Sheikhi A, et al. Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis [J]. Obes Surg, 2019, 29(8): 2631-2647.
[30]
Xu R, Zhu C, Li Y, et al. Gastric Bypass Regulates Early Inflammatory Responses in High-Fat Diet-Induced Obese Mice [J]. J Surg Res, 2022, 273: 161-171.
[31]
Aguiar IC, Freitas WR, Jr. Santos IR, et al. Obstructive sleep apnea and pulmonary function in patients with severe obesity before and after bariatric surgery: a randomized clinical trial [J]. Multidiscip Respir Med, 2014, 9(1): 43.
[32]
Lin SY, Su YX, Wu YC, et al. Management of paediatric obstructive sleep apnoea: A systematic review and network meta-analysis [J]. Int J Paediatr Dent, 2020, 30(2): 156-170.
[33]
Ahmed B, Ammori B J, Akhtar K, et al. Weight loss and metabolic outcomes in women with or without polycystic ovarian syndrome after Roux-en-Y gastric bypass: A case-matched study [J]. Surgeon, 2022, 20(3): 137-141.
[34]
Fisher DP, Liu L, Arterburn D, et al. Remission and Relapse of Hypertension After Bariatric Surgery: A Retrospective Study on Long-Term Outcomes [J]. Ann Surg Open, 2022, 3(2): e158.
[35]
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [J]. Jama, 2004, 292(14): 1724-1737.
[36]
Porthan K, Kenttä T, Niiranen TJ, et al. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death [J]. Int J Cardiol, 2019, 276: 125-129.
[37]
Oliveras A, Molina L, Goday A, et al. Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin-angiotensin system [J]. J Clin Hypertens (Greenwich), 2021, 23(1): 181-192.
[38]
Piché ME, Clavel MA, Auclair A, et al. Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization [J]. Metabolism, 2021, 119: 154773.
[39]
Sarmiento-Cobos M, Rivera C, Okida LF, et al. Left ventricular mass index and ventricular contractility improvement in patients with severe obesity following rapid weight loss after bariatric surgery [J]. Surg Obes Relat Dis, 2021, 17(6): 1140-1145.
[40]
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects [J]. N Engl J Med, 2007, 357(8): 741-752.
[41]
van Veldhuisen SL, Gorter TM, van Woerden G, et al. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis [J]. Eur Heart J, 2022, 43(20): 1955-1969.
[42]
Fenske W, Athanasiou T, Harling L, et al. Obesity-related cardiorenal disease: the benefits of bariatric surgery [J]. Nat Rev Nephrol, 2013, 9(9): 539-551.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[3] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[4] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[5] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[6] 颜帅, 胡旭, 苟晓梅, 谢铭. 腹腔镜胃袖状切除术后并发症处置策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 220-224.
[7] 赵帅, 王伟, 李瑞奇, 周家杰, 王道荣. 3D腹腔镜下袖状胃切除术治疗肥胖合并2型糖尿病的临床疗效及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 146-149.
[8] 刘盾, 潘晟. 不同入路腹腔镜袖状胃切除术用于肥胖症合并2型糖尿病的效果[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 150-154.
[9] 连奕豪, 易加祎, 张青. 视网膜血管迂曲度与心血管疾病危险因素相关性的研究进展[J]. 中华眼科医学杂志(电子版), 2024, 14(02): 119-124.
[10] 孙秀芹, 高美娟, 张琼阁, 吕凯敏, 王宏宇. 京西地区无心血管病史2型糖尿病中老年人群患心血管疾病的危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(03): 245-252.
[11] 颜宥彤, 赵锐, 万谦益, 张贵祥, 沈弘毅, 程中, 陈亿. GLP-1受体激动剂——司美格鲁肽的应用及安全性[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 88-93.
[12] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库:2023年度报告[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 73-83.
[13] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
[14] 邢颖, 闫文貌. 单孔腹腔镜袖状胃切除术发展现状[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 133-137.
[15] 中国医师协会外科医师分会肥胖和糖尿病外科专家工作组. 减重手术相关贫血管理策略中国专家共识(2024版)[J]. 中华肥胖与代谢病电子杂志, 2024, 10(01): 1-8.
阅读次数
全文


摘要